Johns Hopkins University

Johns Hopkins University

Contents

Location
Physicians
NABTT Protocol Availability
Contact Information

Location

Johns Hopkins Hospital
600 North Wolfe Street
Baltimore, MD 21287

Physician	Stuart Grossman, MD	Henry Brem, MD	Larry Kleinberg, MD
Specialty	Neuro-Oncology	Neurosurgery	Radiation Oncology
Address	Johns Hopkins Hospital Cancer Research Building, G93 1650 Orleans Street Baltimore, MD 21231-1000	Johns Hopkins Hospital Department of Neurosurgical Oncology, Meyer 7-109 600 North Wolfe Street Baltimore, MD 21287	Johns Hopkins Hospital Weinberg Building/ RAD ONC 401 N. Wolfe Street Baltimore, MD 21231
Phone Number	410-955-8837	410-614-0477	410-614-2597
Email	grossman@jhmi.edu	hbrem@jhmi.edu	kleinla@jhmi.edu

Physician	John Laterra, MD	Alessandro Olivi, MD	Jon Weingart, MD
Specialty	Neurology	Neurosurgery	Neurosurgery
Address	Johns Hopkins Hospital Dept. of Neurology, Carnegie 490 600 N. Wolfe Street Baltimore, MD 21287	Johns Hopkins Hospital Department of Neurosurgery, Meyer 9-100 600 North Wolfe Street Baltimore, MD 21287	Johns Hopkins Hospital Department of Neurosurgery, Harvey 811 600 North Wolfe Street Baltimore, MD 21287
Phone Number	410-614-3853	410-550-0465 410-955-0703	410-614-3052
Email	laterra@kennedykrieger.org	aolivi@jhmi.edu	jweingar@jhmi.edu

NABTT Protocol Availability

Class A: (Newly Diagnosed Glioblastoma Multiforme with Measurable Disease)

Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults with Newly Diagnosed Malignant Glioma

Class B: (Newly Diagnosed Glioblastoma Multiforme, Measurable/Non Measurable Disease)

Phase I Study of Combined Radiotherapy and Arsenic Trioxide for the Treatment of Newly Diagnosed Malignant Glioma
A Phase II Trial of Talampanel in Conjunction with Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme
A Safety Run-In/Randomized Phase II Trial of EMD 121974 in Conjunction with Concomitant Temozolomide and Adjuvant Temozolomide with Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme
A Phase II Trial of Radiation Plus Temozolomide Followed by Adjuvant Temozolomide and Poly-ICLC in Patients with Newly Diagnosed Glioblastoma Multiforme

Class C: (Recurrent High Grade Astrocytoma, with Measurable Disease)

Phase I Evaluation of the Safety of PS341 in the Treatment of Recurrent Gliomas
A Phase I, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients with MTAP-Deficient High Grade Recurrent Malignant Gliomas
A Phase I Trial of BAY 43-9006 for Patients with Recurrent or Progressive Malignant Glioma

Class D: (Locally Recurrent High Grade Astrocytoma)

A Pharmacokinetic Study of Methotrexate Using an Intratumoral Microdialysis Catheter

Class E: (Histology other than High Grade Astrocytoma)

A Phase II Study of Anti-CD20 Monoclonal Antibody (Rituximab) Therapy for Patients with Refractory or Relapsed Primary Central Nervous System Lymphoma (PCNSL)

Class F: (Non "Therapeutic" Protocols)

A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas
Pilot Study of Thrombophilic States in Patients with High-Grade Gliomas
CD4 Count and Risk of Infection in Patients with Brain Tumors
Identification of Hypermethylated Serum Tumor DNA in High Grade Glioma Patients and Correlation with Magnetic Resonance Imaging Findings

For information regarding the protocols available at this center, please contact:

Deanna Glass-Macenka, RN, BSN
Surgical Research Nurse
Johns Hopkins Hospital
Department of Neurosurgery, Meyer 9-100
600 N. Wolfe Street
Baltimore, MD 21287
Telephone: 410-502-8273
dglassma@jhmi.edu

Kelly Szajna RN, BCN
Research Nurse
Johns Hopkins Hospital
Cancer Research Building, G87
1650 Orleans Street
Baltimore, MD 21231-1000
Telephone: 410-502-5343
kszajna1@jhmi.edu